DK0870197T4 - Anvendelse af nuclear magnetisk resonans til design af ligander rettet mod biomolekyler - Google Patents

Anvendelse af nuclear magnetisk resonans til design af ligander rettet mod biomolekyler

Info

Publication number
DK0870197T4
DK0870197T4 DK96939709T DK96939709T DK0870197T4 DK 0870197 T4 DK0870197 T4 DK 0870197T4 DK 96939709 T DK96939709 T DK 96939709T DK 96939709 T DK96939709 T DK 96939709T DK 0870197 T4 DK0870197 T4 DK 0870197T4
Authority
DK
Denmark
Prior art keywords
target molecule
ligands
design
magnetic resonance
nuclear magnetic
Prior art date
Application number
DK96939709T
Other languages
Danish (da)
English (en)
Other versions
DK0870197T3 (da
Inventor
Stephen W Fesik
Philip J Hajduk
Edward T Olejniczak
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27415774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0870197(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/558,633 external-priority patent/US5891643A/en
Priority claimed from US08/744,701 external-priority patent/US5989827A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of DK0870197T3 publication Critical patent/DK0870197T3/da
Application granted granted Critical
Publication of DK0870197T4 publication Critical patent/DK0870197T4/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/4633—Sequences for multi-dimensional NMR
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK96939709T 1995-11-14 1996-11-13 Anvendelse af nuclear magnetisk resonans til design af ligander rettet mod biomolekyler DK0870197T4 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/558,633 US5891643A (en) 1995-11-14 1995-11-14 Use of nuclear magnetic resonance to design ligands to target biomolecules
US67890396A 1996-07-12 1996-07-12
US08/744,701 US5989827A (en) 1995-11-14 1996-10-31 Use of nuclear magnetic resonance to design ligands to target biomolecules
PCT/US1996/018312 WO1997018469A2 (fr) 1995-11-14 1996-11-13 Utilisation de la resonance magnetique nucleaire pour designer des ligands qui se lient a des biomolecules cibles

Publications (2)

Publication Number Publication Date
DK0870197T3 DK0870197T3 (da) 2001-08-27
DK0870197T4 true DK0870197T4 (da) 2007-02-26

Family

ID=27415774

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96939709T DK0870197T4 (da) 1995-11-14 1996-11-13 Anvendelse af nuclear magnetisk resonans til design af ligander rettet mod biomolekyler

Country Status (12)

Country Link
EP (1) EP0870197B2 (fr)
JP (1) JP3300366B2 (fr)
AT (1) ATE201768T1 (fr)
AU (1) AU711092B2 (fr)
DE (1) DE69613146T3 (fr)
DK (1) DK0870197T4 (fr)
ES (1) ES2159056T5 (fr)
GR (1) GR3036454T3 (fr)
IL (1) IL123572A (fr)
MX (1) MX9803805A (fr)
PT (1) PT870197E (fr)
WO (1) WO1997018469A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010004528A1 (en) * 1995-11-14 2001-06-21 Stephen W. Fesik Use of 13c nuclear magnetic resonance to detect binding to target molecules
US6344330B1 (en) 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
EP1104488B1 (fr) * 1998-07-21 2006-10-25 Rutgers, The State University Etablissement de lien entre une sequence de gene et une fonction de gene par determination de la structure de proteine en trois dimensions (3d)
US6333149B1 (en) 1999-06-04 2001-12-25 Triad Biotechnology, Inc. NMR-solve method for rapid identification of bi-ligand drug candidates
US6764858B2 (en) 1999-09-29 2004-07-20 Pharmacia & Upjohn Company Methods for creating a compound library
US6677160B1 (en) 1999-09-29 2004-01-13 Pharmacia & Upjohn Company Methods for creating a compound library and identifying lead chemical templates and ligands for target molecules
GB9925677D0 (en) * 1999-10-29 1999-12-29 Pharmacia & Upjohn Spa Use of double-quantum 1H-NMR spectroscopy for the identification of ligands interacting with target biomolecules
WO2001062688A2 (fr) * 2000-02-25 2001-08-30 Wyeth Procede de conception de medicaments fondes sur la structure utilisant la spectrometrie de masse et la resonance magnetique nucleaire
EP1322942B1 (fr) 2000-09-27 2014-03-26 Universiteit Leiden Application de la rmn la d couverte de ligands ou la recherche syst matique de m dicaments
US7653490B2 (en) 2001-09-10 2010-01-26 Triad Liquidating Company LLC Nuclear magnetic resonance assembly of chemical entities
NO20025738D0 (no) * 2002-11-29 2002-11-29 Amersham Health As Metode
JP4192078B2 (ja) 2003-11-26 2008-12-03 株式会社日立製作所 核磁気共鳴方法
JP4475237B2 (ja) * 2004-02-02 2010-06-09 三菱化学株式会社 Ｎｍｒシグナル帰属方法
EP2013624B1 (fr) 2006-03-14 2011-08-03 Universität Basel Procédé d'identification de nouvelles têtes de série pour des médicaments candidats
WO2019060917A2 (fr) * 2017-09-25 2019-03-28 Skyhawk Therapeutics, Inc. Procédés et compositions de criblage et d'identification de modulateurs d'épissage
CN117912601A (zh) * 2024-01-26 2024-04-19 苏州腾迈医药科技有限公司 分子构象的展示方法及装置、介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010140A2 (fr) * 1989-12-29 1991-07-11 University Technologies International Inc. Methodes de modelage des structures tertiaires de ligands biologiquement actifs, y compris leurs agonistes et antagonistes et nouveaux antagonistes synthetiques bases sur l'angiotensine
US5393669A (en) * 1993-02-05 1995-02-28 Martek Biosciences Corp. Compositions and methods for protein structural determinations
US8558663B2 (en) † 2007-11-30 2013-10-15 Bank Of America Corporation Integration of facial recognition into cross channel authentication
DE102008042959A1 (de) † 2008-10-20 2010-04-22 Zf Friedrichshafen Ag Verfahren zur Steuerung eines Kraftfahrzeug-Antriebsstrangs
US8678903B1 (en) † 2012-09-13 2014-03-25 Chia-Yen Lin Mobile device having a virtual spin wheel and virtual spin wheel control method of the same

Also Published As

Publication number Publication date
AU7680496A (en) 1997-06-05
EP0870197A2 (fr) 1998-10-14
DK0870197T3 (da) 2001-08-27
AU711092B2 (en) 1999-10-07
MX9803805A (es) 1998-09-30
ES2159056T3 (es) 2001-09-16
JP2002510384A (ja) 2002-04-02
ATE201768T1 (de) 2001-06-15
GR3036454T3 (en) 2001-11-30
JP3300366B2 (ja) 2002-07-08
WO1997018469A3 (fr) 1997-08-07
IL123572A (en) 2004-06-01
DE69613146D1 (de) 2001-07-05
IL123572A0 (en) 1998-10-30
DE69613146T2 (de) 2003-01-16
EP0870197B1 (fr) 2001-05-30
DE69613146T3 (de) 2007-06-14
ES2159056T5 (es) 2007-07-16
EP0870197B2 (fr) 2006-11-08
PT870197E (pt) 2001-11-30
WO1997018469A2 (fr) 1997-05-22

Similar Documents

Publication Publication Date Title
DK0866967T4 (da) Anvendelse af kernemagnetisk resonans til identifikation af ligander til mål-biomolekyler
DK0870197T3 (da) Anvendelse af nuclear magnetisk resonans til design af ligander rettet mod biomolekyler
CA2653517A1 (fr) Procede de conception d'un medicament
Brechbiel et al. Preparation of the Novel Chelating Agent N-(2-Aminoethyl)-trans-1, 2-diaminocyclohexane-N, N ‘, N ‘‘-pentaacetic Acid (H5CyDTPA), a Preorganized Analogue of Diethylenetriaminepentaacetic Acid (H5DTPA), and the Structures of BiIII (CyDTPA) 2-and BiIII (H2DTPA) Complexes
Ernsting et al. 103Rh NMR spectroscopy and its application to rhodium chemistry
ATE214396T1 (de) Kombinatorische bibliotheken aus markierten biochemischen verbindungen und verfahren zu ihrer herstellung
ATE216777T1 (de) Affinitäts-selektion von liganden mittels massenspektroskopie
Polukeev et al. Iridium hydride complexes with cyclohexyl-based pincer ligands: fluxionality and deuterium exchange
Hinman et al. Protonolysis of dimethylplatinum (II) complexes: Primary attack at metal or ligand
Reveco et al. Study of a cyclometalated complex of ruthenium by 400-MHz two-dimensional proton NMR
Pregosin et al. 2-D NMR Spectroscopy of chiral phosphine complexes. Applications to problems related to enantioselective homogeneous catalysis
Mizuta et al. Palladium (II) and platinum (II) complexes of a tetraphosphamacrocycle. X-ray crystal structures of phosphorus analogs of a (tetramethylcyclam) metal complex1
Klatt et al. Spectroscopic characterization of molybdenum dinitrogen complexes containing a combination of di-and triphosphine coligands: 31P NMR analysis of five-spin systems
JP2003513290A (ja) ターゲット生体分子と相互作用するリガンドの同定のための二量子１ｈ−ｎｍｒスペクトロスコピーの使用
Juarez-Garcia et al. Combined Moessbauer and EPR studies of the S= 3 state of an exchange-coupled iron (III)-copper (II) complex: test for quantitative EPR analysis of integer spin systems
Chandrasekhar et al. Cycloalkylaminocyclo-and Polyphosphazenes: X-ray Crystal Structures of g em-Tetrakis (cyclohexylamino) dichlorocyclotriphosphazene and Octakis (cyclopropylamino) cyclotetraphosphazene
Nakazawa et al. Migration of the phosphorus ligand from iron to the cyclopentadienyl ring in complexes of the type (. eta. 5-C5H5)(CO) LFe {P (O) YZ}
Doherty et al. Competitive Nucleophilic Attack at CO and Cβ of the Allenyl Group in [Fe2 (CO) 6 (μ-PPh2)(μ-η1: η2-(H) Cα Cβ CγH2)]. X-ray Crystal Structures of [Fe2 (CO) 5 (μ-PPh2)(μ-η1 (O): η1 (C): η2 (C)-{OC (NtBuH) CH2} C CH2)]⊙ 0.5 C6H14 and [Fe2 (CO) 6 (μ-PPh2)(μ-η1: η1-CH2C (NCyH) CH2]⊙ MeCN
Bell et al. The synthesis, NMR spectroscopy, and X-ray structure of a new rhenium N2S2 chelate complex
Ishii et al. Synthesis of Tungsten (1-Pyridinio) imido Complexes: Facile N− N Bond Cleavage To Form Pyridine from Coordinated Dinitrogen1
Ikura et al. Two-dimensional double-quantum coherence echo correlated spectroscopy in proton NMR
CA2237336A1 (fr) Utilisation de la resonance magnetique nucleaire pour designer des ligands qui se lient a des biomolecules cibles
Konze et al. Palladium Coordination Compounds of σ3λ5-Phosphoranes: First Examples of Phosphonio− Methylene (imino) metallophosphorane [(R3P)(Me3Si) CP (ML n) NSiMe3] and Phosphonio− Methylene (oxo) phosphorane [(R3P)(Me3Si) CP (O) NSiMe3] Ligands
Mashuta et al. Binuclear Schiff base complexes
Mathew et al. Observation of a Large Coupling of a Bound Dihydrogen Ligand to Phosphorus Ligands in trans-[(dppe) 2Ru (η2-H2)(PF (OMe) 2)][BF4] 2 Complex